Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

uniQure N.V. - Ordinary Shares (NQ:QURE)

15.77 -1.34 (-7.86%)

Streaming Delayed Price Updated: 3:09 PM EST, Feb 27, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	4,240,779
Open	17.08
Bid (Size)	15.76 (200)
Ask (Size)	15.78 (600)
Prev. Close	17.11
Today's Range	15.61 - 17.28
52wk Range	7.760 - 71.50
Shares Outstanding	54,865,673
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP

Today 14:30 EST

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP

Today 14:30 EST

Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025?

Via TheNewswire.com

Performance

YTD	-32.6%	-32.6%
1 Month	-35.3%	-35.3%
3 Month	-42.7%	-42.7%
6 Month	-3.0%	-3.0%
1 Year	+35.1%	+35.1%

More News

QURE Or RGNX: Which Gene Therapy Was FDA Chief Really Warning About In Rare Disease Remarks? ↗

Today 0:49 EST

Via Stocktwits

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

February 26, 2026

Via Chartmill

FDA Commissioner Refers To Rare Disease Drug With Associated Morbidity: Analysts Are Divided If Makary Meant Regenxbio Or Uniqure’s Experimental Therapy ↗

February 26, 2026

Via Stocktwits

Thursday's session: top gainers and losers ↗

February 26, 2026

Via Chartmill

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

February 26, 2026

Via NewMediaWire

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

February 26, 2026

Via TheNewswire.com

There are notable gap-ups and gap-downs in today's session. ↗

February 26, 2026

Via Chartmill

UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of Upcoming Deadline

February 26, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE

February 25, 2026

From SkyMedia, LLC

Via GlobeNewswire

UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm

February 25, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

QURE INVESTOR REMINDER: uniQure N.V. Investors Have Until April 13, 2026 To Seek Lead Plaintiff Role

February 25, 2026

From Kirby McInerney LLP

Via Business Wire

QURE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026

February 25, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

February 24, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE

February 24, 2026

From Pomerantz LLP

Via GlobeNewswire

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

February 24, 2026

From Schall Law

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against uniQure N.V.

February 24, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP

February 23, 2026

Via NewMediaWire

uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP

February 23, 2026

Via TheNewswire.com

uniQure to Announce 2025 Financial Results

February 23, 2026

From uniQure Inc.

Via GlobeNewswire

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

February 22, 2026

Via NewMediaWire

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

February 22, 2026

Via TheNewswire.com

uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP

February 21, 2026

Via NewMediaWire

uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP

February 21, 2026

Via TheNewswire.com

Frequently Asked Questions

Is uniQure N.V. - Ordinary Shares publicly traded?

Yes, uniQure N.V. - Ordinary Shares is publicly traded.

What exchange does uniQure N.V. - Ordinary Shares trade on?

uniQure N.V. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for uniQure N.V. - Ordinary Shares?

The ticker symbol for uniQure N.V. - Ordinary Shares is QURE on the Nasdaq Stock Market

What is the current price of uniQure N.V. - Ordinary Shares?

The current price of uniQure N.V. - Ordinary Shares is 15.77

When was uniQure N.V. - Ordinary Shares last traded?

The last trade of uniQure N.V. - Ordinary Shares was at 02/27/26 03:09 PM ET

What is the market capitalization of uniQure N.V. - Ordinary Shares?

The market capitalization of uniQure N.V. - Ordinary Shares is 865.23M

How many shares of uniQure N.V. - Ordinary Shares are outstanding?

uniQure N.V. - Ordinary Shares has 865M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.